Want to join the conversation?
$YELP 2Q15 PR: 3Q15 Outlook: Net revenue is expected to be in the range of $139-142MM, representing growth of approx. 37% compared to 3Q14. Adjusted EBITDA is expected to be in the range of $12-15MM. Stock-based compensation is expected to be in the range of $16-17MM, and depreciation and amortization is expected to be 5%-6% of revenue.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.